Episode 252: Talazoparib and its FDA approval in CRPC
Release Date:
Neeraj Agarwal describes the TALAPRO-2 study and relevance of the HRR biomarker in the 2 cohorts presented. A discussion regarding other PARPis and BRCA1/2 occurs
Episode 252: Talazoparib and its FDA approval in CRPC